The decision comes as the Centers for Disease Control and Prevention launched an investigation after six of the 6.8-million people who took the vaccine developed rare blood clots.
The six cases developed in women between the ages of 18 and 48, with symptoms occurring between six and 13 days after vaccination. According to the CDC and FDA, treatment of this particular type of blood clot is different from a more typical clot.
In a written statement, Tippecanoe County Health Officer Dr. Jeremy Adler noted that the number of people to develop the blood clot is less than one in a million, and it isn’t yet clear if the clotting problem is caused by the vaccine.